Philemon Dauda Shallie1, Thajasvarie Naicker2. 1. Optics and Imaging Centre, School of Laboratory Medicine and Medical Sciences, Nelson Mandela Medical School, University of KwaZulu-Natal, Durban, South Africa. Electronic address: shalliep@ukzn.ac.za. 2. Optics and Imaging Centre, School of Laboratory Medicine and Medical Sciences, Nelson Mandela Medical School, University of KwaZulu-Natal, Durban, South Africa.
Abstract
BACKGROUND: During development, the placenta can be said to be the most important organ, however, the most poorly researched. There is currently a broader understanding of how specific insults during development affect the fetal brain, and also the importance of placental signaling in neurodevelopmental programming. Epigenetic responses to maternal and fetal signals are an obvious candidate for transforming early life inputs into long-term programmatic outcomes. As a mediator of maternal and environmental signals to the developing fetus, epigenetic processes within the placenta are particularly powerful such that alterations of placental gene expression, downstream function, and signalling during foetal development have the potential for dramatic changes in developmental programming. SUMMARY: In this article, we reviewed emerging evidence for a placental role in prenatal neurodevelopmental programming with a specific focus on nutrient and prenatal stress signals integration into chromatin changes; this new understanding, we hope will provide the means for lowering developmentally based disorder risk, and new therapeutic targets for treatment in adulthood. KEY MESSAGES: Based on this review, the placenta is a potent micro-environmental player in neurodevelopment as it orchestrates a series of complex maternal-foetal interactions. Maternal insults to this microenvironment will impair these processes and disrupt foetal brain development resulting in the prenatal programming of neurodevelopmental disorders. These findings should inspire advance animal model and human research drive to appraise gene-environment impacts during pregnancy that will target the developmental cause of adult-onset mental disorders.
BACKGROUND: During development, the placenta can be said to be the most important organ, however, the most poorly researched. There is currently a broader understanding of how specific insults during development affect the fetal brain, and also the importance of placental signaling in neurodevelopmental programming. Epigenetic responses to maternal and fetal signals are an obvious candidate for transforming early life inputs into long-term programmatic outcomes. As a mediator of maternal and environmental signals to the developing fetus, epigenetic processes within the placenta are particularly powerful such that alterations of placental gene expression, downstream function, and signalling during foetal development have the potential for dramatic changes in developmental programming. SUMMARY: In this article, we reviewed emerging evidence for a placental role in prenatal neurodevelopmental programming with a specific focus on nutrient and prenatal stress signals integration into chromatin changes; this new understanding, we hope will provide the means for lowering developmentally based disorder risk, and new therapeutic targets for treatment in adulthood. KEY MESSAGES: Based on this review, the placenta is a potent micro-environmental player in neurodevelopment as it orchestrates a series of complex maternal-foetal interactions. Maternal insults to this microenvironment will impair these processes and disrupt foetal brain development resulting in the prenatal programming of neurodevelopmental disorders. These findings should inspire advance animal model and human research drive to appraise gene-environment impacts during pregnancy that will target the developmental cause of adult-onset mental disorders.
Authors: Susanta K Behura; Pramod Dhakal; Andrew M Kelleher; Ahmed Balboula; Amanda Patterson; Thomas E Spencer Journal: Pharmacol Res Date: 2019-10-07 Impact factor: 7.658
Authors: Joshua L Roffman; Eren D Sipahi; Kevin F Dowling; Dylan E Hughes; Casey E Hopkinson; Hang Lee; Hamdi Eryilmaz; Lee S Cohen; Jodi Gilman; Alysa E Doyle; Erin C Dunn Journal: PLoS One Date: 2021-04-28 Impact factor: 3.240
Authors: Pei Wen Tung; Amber Burt; Margaret Karagas; Brian P Jackson; Tracy Punshon; Barry Lester; Carmen J Marsit Journal: Environ Res Date: 2021-08-27 Impact factor: 6.498
Authors: Jesse M Tehrani; Elizabeth Kennedy; Pei Wen Tung; Amber Burt; Karen Hermetz; Tracy Punshon; Brian P Jackson; Ke Hao; Jia Chen; Margaret R Karagas; Devin C Koestler; Barry Lester; Carmen J Marsit Journal: Pediatr Res Date: 2022-07-29 Impact factor: 3.953
Authors: Serena B Gumusoglu; Akanksha S S Chilukuri; Donna A Santillan; Mark K Santillan; Hanna E Stevens Journal: Trends Neurosci Date: 2020-03-06 Impact factor: 13.837
Authors: Jordan G Schnoll; Brian Temsamrit; Daniel Zhang; Hongjun Song; Guo-Li Ming; Kimberly M Christian Journal: J Neuroimmune Pharmacol Date: 2019-09-11 Impact factor: 4.147
Authors: Koen K A Van Rompay; Lark L Coffey; Tania Kapoor; Anna Gazumyan; Rebekah I Keesler; Andrea Jurado; Avery Peace; Marianna Agudelo; Jennifer Watanabe; Jodie Usachenko; Anil Singapuri; Ramya Immareddy; Amir Ardeshir; Jackson B Stuart; Stylianos Bournazos; Jeffrey V Ravetch; Paul J Balderes; Ivo C Lorenz; Shannon R Esswein; Jennifer R Keeffe; Pamela J Bjorkman; Qiao Wang; Charles M Rice; Margaret R MacDonald; Michel C Nussenzweig; Davide F Robbiani Journal: Proc Natl Acad Sci U S A Date: 2020-03-24 Impact factor: 11.205